DO YOU HAVE TYPE 1 DIABETES?
CURRENTLY USING AN INSULIN PUMP? CONSIDER THE PRONTO-Pump-2 STUDY
You may be eligible for a clinical research study that will test if an investigational ‘ultra-rapid’ insulin can offer better blood glucose control for people with type 1 diabetes who use an insulin pump than currently available rapid-acting insulins.
If you meet the study criteria you will need to attend regular study visits and will receive all study-related visits, lab tests, assessments, as well as study insulins and supplies at no cost. Travel reimbursement will also be available.
We are looking for participants who:
• Are at least 18 years old
• Are diagnosed with type 1 diabetes and have been using insulin continuously for at least 12 months
• Have been using an insulin pump with rapid-acting insulin for at least 6 months
• Have been using the MiniMed 530G (US), Paradigm Revel (US), MiniMed 630G (US and Canada), MiniMed 640G or Paradigm Veo (outside of the US and Canada) insulin pump for at least the past 90 days
For more information, call Metabolic Research Institute (561) 802-3060 or visit: https://www.metabolic-institute.com/csii/